CVS - Invest Smart: 2 Blue Chips To Buy When Others Are Scared
2024-05-09 07:00:00 ET
Summary
- Strong economic growth and a "Goldilocks" jobs report suggest a positive outlook for long-term investors.
- The Mag 7 companies are delivering strong earnings growth, with expectations for continued growth in the coming years.
- There are reasons for economic optimism for the coming years, potentially triggering a historic earnings boom.
- But it's always and forever a market of stocks, not a stock market. Incredible blue-chips are being smashed, offering the opportunity to be "greedy when others are fearful."
- CVS and Humana have been decimated by Medicare Advantage Rates missing expectations and increased medical inflation costs. While both could fall further, both offer high-probability opportunities for potential low-risk income and exceptional returns over the next 3-5 years.
Reasons For Rational Optimism For Investors: Earnings And Strong Economic Growth
I wanted to share some great news for long-term investors.
The market is rocketing higher after what Bloomberg calls a "Goldilocks" jobs report.
The jobs report points to a strong economy, but not too strong. The Fed is now expected to be able to cut rates in September and December, plus potentially end QT (reverse money printing) by year-end.
Following the jobs report, Moody's chief economist, Mark Zandi, told Bloomberg that he sees the data consistent with a soft landing, two rate hikes this year, and most importantly, "at least 2.5% GDP growth this year, just like last year."...
Invest Smart: 2 Blue Chips To Buy When Others Are Scared